TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Risk of death at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: complete miscarriage
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of ST-episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total duration of ST-episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improved attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased psychomotor speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced impulsivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of VEGF and bFGF in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scores of ADL scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Scores of NIHSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sign of active ocular inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: best corrected visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Development of new onset anaemia (NOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma levels of factor VII
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma levels of fibrinogen
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: plasma levels of PAI-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Purging frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity (modified Rankin scale score >2)
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalization >5 days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of aneurysms with complete occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in global functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SAFETY
Endpoint domain: Adverse events/effects
Primary endpoint: REM sleep quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: REM sleep stabilising effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced direct wake to REM transitions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unified Parkinson's Disease Rating Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time spent off
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of on without dyskinesia periods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maternal anxiety during the waiting period
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cough response to tracheal stimulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total lean mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of lean mass increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Parent preferences for incentives
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Three months mortality
Endpoint domain: Mortality/survival
Primary endpoint: Functional independency at three months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Early significant improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: wrist ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SPPB (repeated chair stands)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum ACE concentration change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Weight regain ≤ 20% after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Hypochlorhydria (fasting gastric pH > 4.0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resolution of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with examination experiences
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Geometric mean titers (GMTs) of HI antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Seroconversion rates (SCRs) of HI antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrences of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: extension ROM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Western Ontario and McMaster Universities score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean distal esophageal amplitude for liquid swallows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean distal onset velocity for liquid swallows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean lower esophageal sphincter residual pressure for liquid swallows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: FEV(1)/FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximal expiratory flows at 50% and 25% FVC (MEF(50), MEF(25))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percent weight loss from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of embryos reaching the four-cell or greater stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of embryos reaching the hatched blastocyst stage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accelerated growth of embryos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rectus femoris cross-sectional area (RF-CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: QALYs gained
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative hypoxaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tibia PPA values in running
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum TNF-α concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blood LDL concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of transfused patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding-related re-explorations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SSI rate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Duration of antimicrobial use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: performance measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: faculty ratings of resident competence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean cutaneous blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Release of dietary protein‐derived phenylalanine into the circulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Myofibrillar protein synthesis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eye irritation ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAA/Cr ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Heart Rate (HR) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AB-oxLDL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL-c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates on GAD-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission rates on GAD-7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-treatment scores on CGI-S
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bacterial burden of surgical scrubs at the start of a shift
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients reaching target trough levels of 15 mg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance of Th1/Th2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: satisfactory ratio of successful insertion of LMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of IL-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean healing times of shallow wounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV RNA < or = 20 copies/ml at week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma beta-carotene concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma ascorbic acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Septal and posterior wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average annual change in kidney function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Peak plasma essential amino acids (EAA) concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: eGFRcockcroft change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: three-month survival
Endpoint domain: Mortality/survival
Primary endpoint: levels of HBV DNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rates of recurrence of HBV-associated ACLF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time spent on modules
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: knowledge posttest scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Infections requiring hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: T-helper lymphocytopenia < 250/microl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement in synovial inflammation as measured by IRE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of dying associated with STD
Endpoint domain: Mortality/survival
Primary endpoint: Accuracy of EM navigation compared to manual repositioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically relevant dislocations of the proximal segment
Endpoint domain: Adverse events/effects
Primary endpoint: Orthodontic pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain perception during obstetric labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SBS values (MPa)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained euthymia (Months Well)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: proportion of relapse after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Release time from the hospital
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student's mean scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Student's confidence in reading research papers
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean pain score during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: discharge from the hospital after initial treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CoQ10 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of adverse events during hospital stay
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion requiring ambulance transport within 6 months after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: CDT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time required to obtain physician consent
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of occurrence of acute or chronic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypopharyngeal lacerations or hematomas
Endpoint domain: Adverse events/effects
Primary endpoint: Hypopharyngeal contacts
Endpoint domain: Adverse events/effects
Primary endpoint: alveolar to arterial oxygen tension gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: F-shunt
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Validity and reliability of the SRI questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: alcohol-related consequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left atrial volume/BSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total pain relief values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset of perceptible and meaningful pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of scotomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean terminal elimination half-life (t 1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dose-normalized areas under the concentration-time curve (AUCnorm(dose))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of MAO-B activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: V(T)-V(E) responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HR-VO(2) responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tendon structure and dimensions on UTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance covered in the 12-min walking test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in one-leg stand duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of change in mean posterior-wall cIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average load to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tendon injury
Endpoint domain: Adverse events/effects
Primary endpoint: Periodontal health improvement (PI and BOP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dentin hypersensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: risk of radiographic failure
Endpoint domain: Mortality/survival
Primary endpoint: Risk for ventricular arrhythmia (VA)
Endpoint domain: Mortality/survival
Primary endpoint: Risk for ventricular arrhythmia or death
Endpoint domain: Mortality/survival
Primary endpoint: wrinkle severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global aesthetic scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Blood lactate values at the 3‐min recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to peak power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent with systolic arterial blood pressure below 90 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nonresponse to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: stop signal reaction time (SSRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Scale for the Elderly (PASE) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF‐12 Physical and Mental Health scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: HBD-2 expression in skin lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percentage reduction in forearm flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Mean levels of E2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Decreases of total and low-density lipoprotein (LDL) cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reductions of mean systolic and diastolic blood pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LV reverse dyssynchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TnI level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frankel classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: CD compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DC compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident hip fractures
Endpoint domain: Mortality/survival
Primary endpoint: Incident spine fractures
Endpoint domain: Mortality/survival
Primary endpoint: Incident lower arm fractures
Endpoint domain: Mortality/survival
Primary endpoint: No sickness absence benefit received
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of ≥50% reduction in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of ≥75% reduction in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrollment rate of high-risk patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality Assurance Component (QAC) scores
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Preference for denture technique
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: incidence of feeling cold
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of thirst / having a dry mouth
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: duration of fasting for fluids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer episodes of AOM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer surgical procedures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: More mean surgery-free months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Response criteria during clozapine treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complication rate during endoscopy
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of relaparotomy
Endpoint domain: Adverse events/effects
Primary endpoint: Levels of interferons and ISGs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptability of interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mouth opening ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein deposits on contact lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular surface bacterial environment changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contact lens intolerance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status